Authors
Latest:
Investigators research ocular health after space flightSpaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Latest:
Exploring four decades of change in retinaAdvances in treatment and surgical techniques have transformed patient care.
Latest:
AAO 2024: Reduction in IOP after switching to latanoprostene bunod in glaucoma patients in real-world clinical practiceConstance O. Okeke, MD, shared insights from on her presentation entitled, "Reduction in IOP after switching to latanoprostene bunod in glaucoma patients in real-world clinical practice," which was given at the American Academy of Ophthalmology held in Chicago, Illinois.
Latest:
Intravitreal injections and endophthalmitis: Does lidocaine gel change the risk of the infection?This research was a finalist in the 2020 Ophthalmology Times® Research Scholar Honoree Program.
Latest:
ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine eventThe first SightLine meeting, held pre-ASCRS, reveals insights on physician-industry relationships, mentorship opportunities, and the practical applications of AI in healthcare.
Latest:
AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MDA combination of canaloplasty and goniotomy provides sustained IOP reduction and decreases medication burden with a strong safety profile, making it a valuable option for glaucoma management.
Latest:
Ultra-widefield imaging can enhance efficiency for practicesPhysicians can discover, diagnose, document, treat diseases that might go undetected
Latest:
Digital patient engagement tackles the labor crisis, improves the patient experienceFor health care workers, the pandemic has led to increased burnout, concerns about workplace safety, and staffing shortages that threaten not only patient care but also the entire provider ecosystem.
Latest:
Evaluating the efficacy of water-free cyclosporine in dry eye diseaseCyclosporine superior to vehicle, improves corneal staining in dry eye disease
Latest:
AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomesThe research analyzed the 1-year outcomes of 132 eyes, evaluating mean IOP, baseline changes, medication reduction, and stratifying the results by race (African American vs Caucasian) and glaucoma severity (mild, moderate, severe).
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
A case of DME with persistent subretinal fluidDr. London discusses a case of diabetic macular edema (DME) with persistent subretinal fluid, emphasizing the diagnostic considerations, treatment options, and the implications for patient outcomes in the context of evolving therapeutic approaches.
Latest:
New molecule for allergic conjunctivitis makes debutFirst new therapy in nearly a decade offers another option for physicians, patients
Latest:
EnVision Summit 2025: Glaucoma with co-existing ocular co-morbiditiesAt the EnVision Summit 2025 in San Juan, Puerto Rico, Poonam Misra, MD, and Alcina Lidder, MD, gave advice on managing glaucoma in patients with other ocular co-morbidities such as myopia and those who have undergone corneal transplantation.
Latest:
National Women Physicians Day: Kathryn A. Colby, MD, PhD’s reflections on advancing women in ophthalmologyColby highlights the strides made and challenges that remain for women in ophthalmology, emphasizing the importance of mentorship, individualized professional growth, and resilience in a competitive field, drawing from her experience as Chair of the Department of Ophthalmology at NYU Grossman School of Medicine.
Latest:
Staying the course in shifting windsCEO Stephen McLeod, MD, outlines the American Academy of Ophthalmology's commitment to advocating for evidence-based, sustainable, and equitable reforms that prioritize public health and access to quality care.
Latest:
Early visual functions deficiency and OCT-A changes at the preclinical stage of diabetic retinopathyFuture investigations will assess findings, evaluate their prognostic value.
Latest:
Retrospective cohort study looks at adverse intraoperative and postoperative events following cataract surgery for patients with prior intravitreal injections and incisional retinal proceduresThe project, presented by Colton Hill, MPH, on behalf of the Dean McGee Eye Institute, looks at complication rates during cataract surgery or after cataract surgery for patients with prior intravitreal injections or incisional retinal procedures.
Latest:
Deciding Between Multifocals and Light Adjustable LensesAn expert weighs in on considerations involved in the choice between multifocal and light adjustable lenses.
Latest:
Faster epithelial healing for patients with corneal abrasion and PRKShifting the treatment paradigm can lead to less pain and inflammation.
Latest:
A guide to treating severe ocular graft-vs-host diseaseThe key to successful management of oGVHD is early diagnosis
Latest:
ASCRS 2025: Visual and patient-reported outcomes following bilateral Odyssey implantationAlex Hacopian, MD, highlights how a recent ambispective study demonstrated strong visual acuity outcomes and patient satisfaction following bilateral implantation of an advanced presbyopia-correcting intraocular lens.
Latest:
Innovations in the treatment of corneal dystrophiesPhysician outlines the latest emerging technologies to treat the condition.
Latest:
Small-aperture single-piece IOL could fill unmet need in patientsOptics block out-of-focus and stray light, allow continuum of vision.
Latest:
Eye Care Products in the Pipeline for Dry Eye DiseaseUnique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Latest:
Getting ophthalmic biosimilars to market continues to prove difficultRepresentatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have.
